VORSCHAU
Frühere Meldungen
PRESSETERMINE
AKTUELLES PRESSEFOTO
IR Nachrichten
19.05.2024 10:00
Small- & MicroCap Investment
19.05.2024 09:30
Small- & MicroCap Investment
19.05.2024 09:00
Small- & MicroCap Investment
EUROPA NACHRICHTEN
ADHOC
Mo, 18.03.2024 15:00
pta20240318028
Business news for the stock market
Medigene AG: Medigene AG to report full year 2023 financial results on March 28, 2024Planegg/Martinsried (pta028/18.03.2024/15:00) - Medigene AG (Medigene or the "Company", FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, will report financial results and provide a corporate update for the fiscal year ended December 31, 2023, on Thursday, March 28, 2024. Following the release of the full year 2023 earnings results and annual report on Medigene's website, the Company will host a conference call that same day at 3 pm CET / 10 am ET. Full details for the conference call and webcast are as follows:
Participants may pre-register and will receive dedicated dial-in details to easily and quickly access the call with the above registration link for the conference call. Please dial in 10 minutes ahead of time to ensure a timely start of the conference call. Following the call, an archived webcast will be accessible on the Investors & Media section on Medigene's website: https://medigene.com/investors-media/reports-presentations/ --- end of press release ---
About Medigene AG
Medigene AG
In case you no longer wish to receive any information about Medigene, please inform us by e-mail (investor@medigene.com). We will then delete your address from our distribution list.
(Ende)
FOTODIENST
PRESSETEXT.TV
Walter Oblin sieht Post auf Wachstumskurs 18.04.2023 ETARGET
FOCUSTHEMA
SPECIALS
Werbung
middleAdvertising
|